Towards Healthcare
Life Science Chemical Biotech Instrumentation Market Surpass USD 50.85 Bn by ...

Life Science Chemical Biotech Instrumentation Market 2025 Driven by Drug Discovery, Chromatography Dominance & Bioprocess Innovation

Based on market forecasts, the life science chemical biotech instrumentation sector will expand from USD 34.23 billion in 2024 to USD 50.85 billion by 2034, experiencing a CAGR of 4.05%. The growing research and development activities and technological advancements drive the global market. The presence of a robust biopharma infrastructure and increasing investments contribute to North America’s dominance.

  • Insight Code: 5870
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

FAQ's

The life science chemical biotech instrumentation market is projected to reach USD XX billion by 2034, growing at a CAGR of XX% from 2025 to 2034.

North America is leading the life science chemical biotech instrumentation market due to the availability of state-of-the-art research and development facilities, robust biopharma infrastructure, and increasing investments.

The life science chemical biotech instrumentation market involves 5 segments, including by product type, by technology, by application, by end-user, and by region.

Some key players include Thermo Fisher Scientific, PerkinElmer, and Bio-Rad Laboratories.

Key trends include the growing research and development activities, advancements in life science instruments, and stringent regulatory policies.

BIOTE Canada, Germany Trade & Invest, Agency for Science, Technology, and Research Singapore, Cordis Europe